• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Moolec Science to Host Fiscal Year 2023 Business Update Conference Call

    10/17/23 5:00:00 PM ET
    $MLEC
    Blank Checks
    Finance
    Get the next $MLEC alert in real time by email

    LUXEMBOURG / ACCESSWIRE / October 17, 2023 / Moolec Science SA (NASDAQ:MLEC); ("Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today that it will release its Business Update for the Fiscal Year 2023 on Friday, October 20, 2023, after the market closes.


    Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, Chief Science Officer Amit Dhingra, and Head of Investor Relations Martín Taraciuk will host a live Conference Call, followed by a question-and-answer session, on Monday, October 23, 2023 at 09:00am ET.

    The Conference Call will be accompanied by a presentation, which can be viewed during the webcast. A replay and the pdf version of the presentation will be available approximately two hours after the conclusion of the live event via the company's Investor Relations website.

    Connection Details:

    • When: October 23, 2023 - 09:00 AM Eastern Time (US and Canada)
    • Topic: Moolec Science - Business Update Conference Call 4Q FY2023
    • Link to join the webinar: https://us06web.zoom.us/j/84198066199
    • Dial In: +1 507 473 4847 US | Webinar ID: 841 9806 6199
    • International numbers available: https://us06web.zoom.us/u/kbOMXArmP

    About Moolec Science SA

    Moolec is a science-based ingredient company leader in the use of Molecular Farming technology for food. The Company's mission is to create unique food ingredients by engineering plants with animal protein genes. Its purpose is to redefine the way the world produces animal-based food, for good and for all. Moolec's technological approach aims to have the cost structure of plant-based solutions with the organoleptic properties and functionality of animal-based ones. Moolec's technology has been under development for more than a decade and is known for pioneering the production of a bovine protein in a crop for the food industry. The Company's product portfolio and pipeline leverages the agronomic efficiency of broadly used target crops, like soybean and safflower. Recently, it acquired plant-based ingredient capabilities to consolidate Molecular Farming Technology. Moolec has a growing international patent portfolio (25, both granted and pending) for its Molecular Farming technology. The Company is run by a diverse team of Ph.Ds and Food Insiders, and operates in the United States, Europe, and South America.

    Forward-Looking Statements

    This press release contains "forward-looking statements." Forward-looking statements may be identified by the use of words such as "forecast," "intend," "seek," "target," "anticipate," "believe," "expect," "estimate," "plan," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements with respect to performance, prospects, revenues, and other aspects of the business of Moolec are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors, about which we cannot be certain. We cannot assure you that the forward-looking statements in this press release will prove accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results, including, among others, changes in applicable laws or regulations, the possibility that Moolec may be adversely affected by economic, business and/or other competitive factors, costs related to the scaling up of Moolec's business and other risks and uncertainties, including those included under the header "Risk Factors" in the Moolec' Annual Report on Form 20-Filled with the U.S. Securities and Exchange Commission ("SEC"), as well as Moolec's other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Accordingly, you should not put undue reliance on these statements.

    Contact Information:

    Catalina Jones
    Chief of Staff & Sustainability
    [email protected]

    Martín Taraciuk
    Investor Relations
    [email protected]

    Michael Bowen
    ICR, LLC
    [email protected]

    SOURCE: Moolec Science

    .

    View source version on accesswire.com:
    https://www.accesswire.com/793830/moolec-science-to-host-fiscal-year-2023-business-update-conference-call

    Get the next $MLEC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MLEC

    DatePrice TargetRatingAnalyst
    9/27/2023$5.00Buy
    ROTH MKM
    More analyst ratings

    $MLEC
    SEC Filings

    See more
    • SEC Form 6-K filed by Moolec Science SA

      6-K - Moolec Science SA (0001937737) (Filer)

      5/13/25 11:33:56 AM ET
      $MLEC
      Blank Checks
      Finance
    • SEC Form 6-K filed by Moolec Science SA

      6-K - Moolec Science SA (0001937737) (Filer)

      4/29/25 5:29:32 PM ET
      $MLEC
      Blank Checks
      Finance
    • SEC Form 6-K filed by Moolec Science SA

      6-K - Moolec Science SA (0001937737) (Filer)

      4/22/25 8:30:49 PM ET
      $MLEC
      Blank Checks
      Finance

    $MLEC
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $MLEC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Moolec Has Received USDA Approval for the First Genetically Modified Pea in History

      LUXEMBOURG / ACCESSWIRE / October 16, 2024 / Moolec Science SA (NASDAQ:MLEC) ("the Company"), a leader in Molecular Farming technology, announced today that the U.S. Department of Agriculture's ("USDA") Animal and Plant Health Inspection Service ("APHIS") has completed its Regulatory Status Review ("RSR") for the Company's genetically engineered ("GE") peas which produce iron through bovine meat proteins. This is the third regulatory clearance from USDA-APHIS achieved by Moolec in an 18-month window, alongside its genetically engineered safflower and soybean for GLASO™ and Piggy Sooy™ products, respectively. Access the official USDA-APHIS publication here. "With USDA approval for our GE pe

      10/16/24 6:00:00 AM ET
      $MLEC
      Blank Checks
      Finance
    • Moolec Science Presents Fiscal Year 2024 Annual Business Update

      LUXEMBOURG / ACCESSWIRE / October 2, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today reported its Business Update for the fourth quarter of Fiscal Year 2024 ended June 30, 2024. Moolec Science Logo The main highlights of Moolec's fourth quarter are as follows:GLASO™: The Company announced an offtake agreement with a major global CPG food and pet food company and an R&D collaboration agreement with Bunge. Also, Moolec made significant advancements in both upstream and downstream processes.Piggy Sooy™: Field trials in three different US locations continue on sch

      10/2/24 6:00:00 AM ET
      $MLEC
      Blank Checks
      Finance
    • Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call

      LUXEMBOURG / ACCESSWIRE / September 25, 2024 / Moolec Science SA (NASDAQ:MLEC)("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, announced today that it will release its Business Update for the Fourth Quarter and Full Fiscal Year 2024 on Wednesday, October 2, 2024, before the market opens.Moolec Sciences Logo Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, and Chief Science Officer Amit Dhingra, will host a live Conference Call, followed by a question-and-answer session, on Wednesday, October 2, 2024 at 08:30am ET.The Conference Call will be accompanied by a pr

      9/25/24 6:00:00 AM ET
      $MLEC
      Blank Checks
      Finance
    • SEC Form SC 13D filed by Moolec Science SA

      SC 13D - Moolec Science SA (0001937737) (Subject)

      4/17/24 5:14:28 PM ET
      $MLEC
      Blank Checks
      Finance
    • SEC Form SC 13D/A filed by Moolec Science SA (Amendment)

      SC 13D/A - Moolec Science SA (0001937737) (Subject)

      4/10/24 9:39:03 PM ET
      $MLEC
      Blank Checks
      Finance

    $MLEC
    Financials

    Live finance-specific insights

    See more
    • Moolec Science Presents Fiscal Year 2024 Annual Business Update

      LUXEMBOURG / ACCESSWIRE / October 2, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today reported its Business Update for the fourth quarter of Fiscal Year 2024 ended June 30, 2024. Moolec Science Logo The main highlights of Moolec's fourth quarter are as follows:GLASO™: The Company announced an offtake agreement with a major global CPG food and pet food company and an R&D collaboration agreement with Bunge. Also, Moolec made significant advancements in both upstream and downstream processes.Piggy Sooy™: Field trials in three different US locations continue on sch

      10/2/24 6:00:00 AM ET
      $MLEC
      Blank Checks
      Finance
    • Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call

      LUXEMBOURG / ACCESSWIRE / September 25, 2024 / Moolec Science SA (NASDAQ:MLEC)("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, announced today that it will release its Business Update for the Fourth Quarter and Full Fiscal Year 2024 on Wednesday, October 2, 2024, before the market opens.Moolec Sciences Logo Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, and Chief Science Officer Amit Dhingra, will host a live Conference Call, followed by a question-and-answer session, on Wednesday, October 2, 2024 at 08:30am ET.The Conference Call will be accompanied by a pr

      9/25/24 6:00:00 AM ET
      $MLEC
      Blank Checks
      Finance
    • Moolec Science to Host Third Quarter Fiscal Year 2024 Business Update Conference Call

      LUXEMBOURG / ACCESSWIRE / May 23, 2024 / Moolec Science SA (NASDAQ:MLEC)("Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today that it will release its Business Update for the Third Quarter Fiscal Year 2024 on Thursday, May 30, 2024, before the market opens. Moolec Logo Moolec Science Logo Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, and Chief Science Officer Amit Dhingra, will host a live Conference Call, followed by a question-and-answer session, on Thursday, May 30, 2024, at 08:30 a.m. ET.The Conference Call will be accompanied by a presentation

      5/23/24 7:00:00 AM ET
      $MLEC
      Blank Checks
      Finance

    $MLEC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ROTH MKM initiated coverage on Moolec Science with a new price target

      ROTH MKM initiated coverage of Moolec Science with a rating of Buy and set a new price target of $5.00

      9/27/23 7:44:02 AM ET
      $MLEC
      Blank Checks
      Finance